Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jianpi Qinghua Granules for NERD
NCT04324138Phase 1Unknown
- Sponsor
- Xiyuan Hospital
- Start
- Jul 2020
- Primary completion
- Dec 2021
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of jianpi qinghua in non-erosive reflux disease (NERD) (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: Change of visual analogue (VAS) score of reflux symptoms and heartburn at 8 weeks. Status: unknown.
02
Drugs
jianpi qinghua
03
Conditions
non-erosive reflux disease (NERD)
Beyond the preview
Go deeper on NCT04324138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04324138.